Expert Rev Pharmacoecon Outcomes Res
February 2018
Introduction: Australia, England, France and New Zealand use different policies to regulate their medicines market, which can impact on utilisation and price.
Objectives: To compare the prices and utilisation of statins in Australia, England, France and New Zealand from 2011 to 2013.
Methods: Utilisation of statins in the four countries was compared using Defined Daily Doses (DDD) per 1000 inhabitants per year.